RxDoctor Payments Data

Ruslana Kadze

Obstetrics & Gynecology · Tarzana, CANPI 1598825523

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 35.6% of the total. Reporting peaked in 2022 at $688 and has fallen 74.5% since, to $176 in 2023.

$2,328in general payments, 2019–2025

Across 172 payments — averaging $13.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$828
  • Avion Pharmaceuticals$385
  • Myovant Sciences Inc.$228
  • Hologic Sales And Service, LLC$219
  • Pfizer$144
  • Therapeuticsmd, Inc.$123
  • plus $402 from 11 others

What the payments were for

  • Food & beverage$2,28898%
  • Education$402%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,328 in reported general payments places this provider in the 80th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California →

Other obstetrics & gynecology in Tarzana

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →